BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 11505717)

  • 21. Oral contraceptives.
    Maclennan AH
    Curr Ther (Seaforth); 1987 Dec; 28(12):113-22. PubMed ID: 12317413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombosis and the Pill.
    Vessey MP
    Prescr J; 1970 Feb; 10(1):1-7. PubMed ID: 12254686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Contraception for the diabetic woman].
    Arlot S; Mesmacque A; Lalau JD; Quichaud J
    Fertil Contracept Sex; 1988 Nov; 16(11):921-6. PubMed ID: 12282829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Oral contraception, glucid metabolism and monitoring criteria].
    Gaspard U
    Contracept Fertil Sex (Paris); 1988 Feb; 16(2):113-8. PubMed ID: 12342000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Oral contraception and menopausal hormone replacement: effects on hemostasis and risk of venous thromboembolism].
    Bounameaux H; de Moerloose P; Campana A
    Schweiz Med Wochenschr; 1996 Oct; 126(41):1756-63. PubMed ID: 8966508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Oral contraception: evolution of concepts over the last thirty years].
    Belaisch J; Hommais-loufrani B
    Contracept Fertil Sex (Paris); 1987 Nov; 15(11 Suppl):1-8. PubMed ID: 12281408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coagulation and thrombosis with OC use: physiology and clinical relevance.
    Comp PC
    Dialogues Contracept; 1996; 5(1):1-3. PubMed ID: 12347721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen dose in oral contraceptives: FDA committee examines safety and utility of 50 mcg estrogen OCs.
    Contracept Rep; 1994 Mar; 5(1):10-3. PubMed ID: 12287738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of oral estrogen-progestin contraceptives on blood coagulation and assessment of the risk of thromboembolism].
    Surico N; Porcelli A; Petrelli P; Amedeo M; Crivello T; Ferraris G
    Minerva Ginecol; 1988 Sep; 40(9):559-62. PubMed ID: 2975773
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hormonal contraception and risk of venous thromboembolism: When to ask for an assessment of hemostasis? Which parameters?].
    Plu-Bureau G; Horellou MH; Gompel A; Conard J
    Gynecol Obstet Fertil; 2008 Apr; 36(4):448-54. PubMed ID: 18424163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Oral contraceptives and blood platelets].
    Davenas E; Ciavatti M; Poitevin B; Aubin M
    Homeopath Fr; 1985; 73(5):299-305. PubMed ID: 12281246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [How to choose an oral contraceptive in 1984].
    Rozenbaum H
    Contracept Fertil Sex (Paris); 1984 Nov; 12(11):1201-6. PubMed ID: 12266609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral contraceptives and deep venous thrombosis with pulmonary embolism.
    Bouché RT; Medawar SJ; Dockery GL
    J Foot Surg; 1982; 21(4):297-301. PubMed ID: 7186920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prevention of thromboembolic side effects of oral contraceptives: methodologic recommendations].
    Póka R; Balogh I; Ajzner E; Nagy IG
    Orv Hetil; 1998 Apr; 139(14):815-8. PubMed ID: 9569728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Choosing the appropriate oral contraceptive.
    Langer A; Devanesan M; Pelosi MA
    Drug Ther (NY); 1978 Jun; 8(7):112-20. PubMed ID: 12260696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Potential advantages of triphasic combined oral contraceptives in the light of recent epidemiological and endocrinometabolic data].
    Gaspard U; Dubois M
    Contracept Fertil Sex (Paris); 1982 Sep; 10(9):551-60. PubMed ID: 12311606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review.
    Gomes MP; Deitcher SR
    Arch Intern Med; 2004 Oct; 164(18):1965-76. PubMed ID: 15477430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of two oral contraceptives, containing 30 or 20 microg of ethinyl estradiol in combination with gestodene, on blood coagulation and fibrinolysis in Brazilian women.
    Ferreira AC; Montes MB; Franceschini SA; Toloi MR
    Int J Fertil Womens Med; 2001; 46(5):265-70. PubMed ID: 11720199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Metabolic effects of oral contraceptives: influence of the dosage and nature of the substance used].
    Basdevant A
    Contracept Fertil Sex (Paris); 1979 Nov; 4(11):781-5. PubMed ID: 12261846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemostasis and oral contraception.
    Conard J; Samama M; Arkwright S
    Contracept Fertil Sex (Paris); 1976 Dec; 4(8):633-5. PubMed ID: 12259521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.